Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | HPGD | P15428 | 6/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.35 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | RECQL | P46063 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | APEX1 | P27695 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | FYN | P06241 | 2/20 | 0.35 |
| ▸ | MMP9 | P14780 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL246576 | 0.81 | ALDH1A1 (0.39) | ALDH1A1HPGDHSD17B10BCL2L1ALOX15 | |
| SCHEMBL4964114 | 0.79 | HPGD (0.38) | ALDH1A1HPGDHSD17B10ALOX15MAPT | |
| SCHEMBL4964118 | 0.79 | HPGD (0.38) | ALDH1A1HPGDHSD17B10ALOX15MAPT | |
| SCHEMBL18047800 | 0.78 | MAPT (0.44) | ALDH1A1HPGDHSD17B10BCL2L1ALOX15 | |
| SCHEMBL568780 | 0.78 | MEN1 (0.46) | ALDH1A1HPGDHSD17B10ALOX15MAPT | |
| SCHEMBL504078 | 0.78 | MEN1 (0.46) | ALDH1A1HPGDHSD17B10ALOX15MAPT | |
| SCHEMBL817884 | 0.76 | IDO1 (0.36) | ALDH1A1HPGDHSD17B10ALOX15MAPT | |
| SCHEMBL9985286 | 0.75 | MEN1 (0.44) | ALDH1A1HPGDHSD17B10ALOX15MAPT | |
| SCHEMBL9985289 | 0.75 | MEN1 (0.44) | ALDH1A1HPGDHSD17B10ALOX15MAPT | |
| SCHEMBL15226315 | 0.70 | ALDH1A1 (0.37) | ALDH1A1HPGDHSD17B10ALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 492 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676483-A1 | IMPROVED LINKER-PAYLOADS FOR ANTIBODY CONJUGATION, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF | OBI Pharma, Inc. (TW) | 2026-01-14 | — | — | EP | claimed |
| US-12503455-B2 | Nucleic acid-binding photoprobes and uses thereof | ARRAKIS THERAPEUTICS, INC. (US) | 2025-12-23 | — | — | US | claimed |
| WO-2025064733-A1 | IMPROVED LINKER-PAYLOADS FOR ANTIBODY CONJUGATION, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF | OBI PHARMA, INC. (TW) | 2025-03-27 | — | — | WO | claimed |
| US-11807623-B2 | Nucleic acid-binding photoprobes and uses thereof | ARRAKIS THERAPEUTICS, INC. (US) | 2023-11-07 | — | — | US | claimed |
| US-20230312520-A1 | NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF | ARRAKIS THERAPEUTICS, INC. | 2023-10-05 | — | — | US | claimed |
| US-20210147894-A1 | METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELL LYSATES | NORTHWESTERN UNIVERSITY | 2021-05-20 | — | — | US | claimed |
| EP-3717009-A1 | NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF | Arrakis Therapeutics, Inc. (US) | 2020-10-07 | — | — | EP | claimed |
| CN-111386127-A | Nucleic acid-binding light probes and uses thereof | 阿拉基斯医疗公司 | 2020-07-07 | — | — | CN | claimed |
| US-20200179541-A1 | METHODS AND COMPOSITIONS FOR ENZYME-MEDIATED SITE-SPECIFIC RADIOLABELING OF GLYCOPROTEINS | Life Technologies Corporation | 2020-06-11 | — | — | US | claimed |
| WO-2019204346-A1 | METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELLLYSATES | NORTHWESTERN UNIVERSITY (US) | 2019-10-24 | — | — | WO | claimed |
| US-20190270723-A1 | NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF | ARRAKIS THERAPEUTICS, INC. | 2019-09-05 | — | — | US | claimed |
| EP-3472210-A1 | SITE-SPECIFIC CROSSLINKING OF ANTIBODIES | Life Technologies Corporation (US) | 2019-04-24 | — | — | EP | claimed |
| WO-2017218891-A1 | SITE-SPECIFIC CROSSLINKING OF ANTIBODIES | Life Technologies Corporation (US) | 2017-12-21 | — | — | WO | claimed |
| US-12594339-B2 | Lipid prodrugs of JAK inhibitors and uses thereof | SEAPORT THERAPEUTICS, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-12528836-B2 | Dosing regimens | APELLIS PHARMACEUTICALS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| EP-4676483-A1 | IMPROVED LINKER-PAYLOADS FOR ANTIBODY CONJUGATION, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF | OBI Pharma, Inc. (TW) | 2026-01-14 | — | — | EP | disclosed |
| EP-2222341-A1 | ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS | University Of Georgia Research Foundation, Inc. (US) | 2010-09-01 | — | — | EP | disclosed |
| US-20100210854-A1 | Cyclopropenones and the Photochemical Generation of Cyclic Alkynes Therefrom | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2010-08-19 | — | — | US | disclosed |
| WO-2010044752-A1 | AMPHIPHILIC POLYMERS AND NANOCRYSTALS COATED THEREWITH | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-04-22 | — | — | WO | disclosed |
| WO-2009067663-A1 | ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2009-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190270723-A1 | NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF | NSUN3, NSUN2, TARBP1 | ALDH1A1 891/4885HPGD 3022/4885HSD17B10 1668/4885 |
| US-20230312520-A1 | NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF | NSUN3, NSUN2, TARBP1 | ALDH1A1 891/4885HPGD 3022/4885HSD17B10 1668/4885 |
| US-12503455-B2 | Nucleic acid-binding photoprobes and uses thereof | NSUN3, NSUN2, TARBP1 | ALDH1A1 891/4885HPGD 3022/4885HSD17B10 1668/4885 |
| US-20200179541-A1 | METHODS AND COMPOSITIONS FOR ENZYME-MEDIATED SITE-SPECIFIC RADIOLABELING OF GLYCOPROTEINS | ENGASE, FUCA1, GUSB | ALDH1A1 735/4885HPGD 1066/4885HSD17B10 1632/4885 |
| US-12528836-B2 | Dosing regimens | CFD, CFB, VIP | ALDH1A1 4785/4885HPGD 3796/4885HSD17B10 4665/4885 |
| US-11807623-B2 | Nucleic acid-binding photoprobes and uses thereof | NSUN3, NSUN2, TARBP1 | ALDH1A1 891/4885HPGD 3022/4885HSD17B10 1668/4885 |
| US-12594339-B2 | Lipid prodrugs of JAK inhibitors and uses thereof | JAK1, JAK3, JAK2 | ALDH1A1 3461/4885HPGD 3200/4885HSD17B10 544/4885 |
| US-20100210854-A1 | Cyclopropenones and the Photochemical Generation of Cyclic Alkynes Therefrom | WEE1, WEE2, MPI | ALDH1A1 205/4885HPGD 508/4885HSD17B10 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.